Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC

Abstract Background Pioglitazone, a synthetic peroxisome proliferator activated receptor (PPAR-γ) ligand, is known as an antidiabetic drug included in the thiazolidinediones (TZDs) class. It regulates the lipid and glucose cell metabolism and recently a role in the inhibition of numerous cancer cell...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Vincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello, Carminia Maria Della Corte, Giusi Barra, Giuseppe Viscardi, Giovanna Esposito, Francesca Sparano, Teresa Troiani, Erika Martinelli, Michele Orditura, Ferdinando De Vita, Fortunato Ciardiello, Floriana Morgillo
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2019-04-01
סדרה:Journal of Experimental & Clinical Cancer Research
נושאים:
Glitazones
Metabolism
Lung cancer
EMT
Bioenergetics
גישה מקוונת:http://link.springer.com/article/10.1186/s13046-019-1176-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים